BRPI0309787E2 - Polipeptídeo isolado, composição de vacina anti-carrapato de espécies múltiplas, molécula de cdna isolada, vetor de expressão, célula isolada, vacina anti-carrapato de espécie múltipla, e, método de induzir uma resposta imune em um mamífero contra a infestação de carrapato de espécie múltipla e seus patógenos associados - Google Patents

Polipeptídeo isolado, composição de vacina anti-carrapato de espécies múltiplas, molécula de cdna isolada, vetor de expressão, célula isolada, vacina anti-carrapato de espécie múltipla, e, método de induzir uma resposta imune em um mamífero contra a infestação de carrapato de espécie múltipla e seus patógenos associados

Info

Publication number
BRPI0309787E2
BRPI0309787E2 BRC10309787A BRPI0309787A BRPI0309787E2 BR PI0309787 E2 BRPI0309787 E2 BR PI0309787E2 BR C10309787 A BRC10309787 A BR C10309787A BR PI0309787 A BRPI0309787 A BR PI0309787A BR PI0309787 E2 BRPI0309787 E2 BR PI0309787E2
Authority
BR
Brazil
Prior art keywords
tick
species
isolated
inducing
expression vector
Prior art date
Application number
BRC10309787A
Other languages
English (en)
Inventor
De Jesus De La Fuente Jose
M Kocan Katherine
Garcia-Almazan Consuelo
F Blouin Edmour
Original Assignee
Univ Oklahoma State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Oklahoma State filed Critical Univ Oklahoma State
Publication of BRPI0309787A2 publication Critical patent/BRPI0309787A2/pt
Publication of BRPI0309787E2 publication Critical patent/BRPI0309787E2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43527—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from ticks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Insects & Arthropods (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

POLIPEPTÍDEO, COMPOSIÇÃO DE VACINA ANTI-CARRAPATO DE ESPÉCIES MÚLTIPLAS, MOLÉCULA DE CDNA, VETOR DE EXPRESSÃO, CÉLULA, VACINA ANTI-CARRAPATO DE ESPÉCIE MÚLTIPLA, E, USO DE UMA QUANTIDADE IMUNIZANTE EFICAZ DE UM IMUNÓGENO Ampla faixa de antígenos protetivos contra infestações de carrapato, seqüências de gene e proteínas codificadas para tais antígenos, 0 vacinas relacionadas e métodos úteis para induzir uma resposta imune.
BRC10309787A 2002-04-29 2003-04-29 Polipeptídeo isolado, composição de vacina anti-carrapato de espécies múltiplas, molécula de cdna isolada, vetor de expressão, célula isolada, vacina anti-carrapato de espécie múltipla, e, método de induzir uma resposta imune em um mamífero contra a infestação de carrapato de espécie múltipla e seus patógenos associados BRPI0309787E2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37625102P 2002-04-29 2002-04-29
PCT/US2003/013229 WO2003093416A2 (en) 2002-04-29 2003-04-29 Protective antigens for the control of ixodes species infestations

Publications (2)

Publication Number Publication Date
BRPI0309787A2 BRPI0309787A2 (pt) 2017-06-20
BRPI0309787E2 true BRPI0309787E2 (pt) 2022-08-02

Family

ID=29401322

Family Applications (1)

Application Number Title Priority Date Filing Date
BRC10309787A BRPI0309787E2 (pt) 2002-04-29 2003-04-29 Polipeptídeo isolado, composição de vacina anti-carrapato de espécies múltiplas, molécula de cdna isolada, vetor de expressão, célula isolada, vacina anti-carrapato de espécie múltipla, e, método de induzir uma resposta imune em um mamífero contra a infestação de carrapato de espécie múltipla e seus patógenos associados

Country Status (6)

Country Link
US (1) US7214784B2 (pt)
EP (1) EP1534328A4 (pt)
AU (1) AU2003223767A1 (pt)
BR (1) BRPI0309787E2 (pt)
MX (1) MXPA04010793A (pt)
WO (1) WO2003093416A2 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6939549B2 (en) * 2000-10-30 2005-09-06 The Board Of Regents For Oklahoma State University Immunoprotective recombinant antigen from anaplasma marginale, vaccine compositions and methods of use
US20050260229A1 (en) * 2000-10-30 2005-11-24 De La Fuente Jose De Jesus Glycans of Anaplasma marginale major surface protein 1a, pharmaceutical compositions and methods of use
US20060040361A1 (en) * 2002-04-29 2006-02-23 The Board Of Regents For Oklahoma State University Protective antigens and vaccines for the control of multi species tick infestations
US20050123554A1 (en) * 2002-04-29 2005-06-09 The Board Of Regents For Oklahoma State University Protective antigens and vaccines for the control of multi species tick infestations
AU2003223767A1 (en) 2002-04-29 2003-11-17 The Board Of Regents For Oklahoma State University Protective antigens for the control of ixodes species infestations
US9265818B2 (en) * 2007-05-04 2016-02-23 The United States Of America, As Represented By The Secretary Of Agriculture Genetically modified Babesia parasites expressing protective tick antigens and uses thereof
BR102013030662B1 (pt) * 2013-11-28 2021-12-28 Universidade De São Paulo - Usp Processo de seleção de antígenos de carrapatos e composições antigênicas anticarrapatos
US10363292B2 (en) * 2016-09-23 2019-07-30 The United States Of America, As Represented By The Secretary Of Agriculture Vaccination with anti-tick antigens to control multiple tick species and disease transmission in white-tailed deer and other host animals

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4447537A (en) * 1981-01-22 1984-05-08 The United States Of Americas As Represented By The Department Of Health And Human Services Tick cell lines
US5587311A (en) * 1986-11-27 1996-12-24 Biotechnology Australia Pty. Ltd. DNA encoding a cell membrane glycoprotein of a tick gut
US6235283B1 (en) * 1986-11-27 2001-05-22 Biotechnology Australia Pty. Ltd. DNA encoding a cell membrane glycoprotein of a tick gut
US5344645A (en) * 1991-03-22 1994-09-06 Center For Innovation And Business Development Foundation Immunogens derived from pathogen-free tick species or cell lines, and tick vaccines derived therefrom
EP0880543A4 (en) * 1995-10-26 2000-08-02 Rhode Island Education ANTIGENS AS VACCINE CANDIDATES FOR THE SPICK-INDUCED LYME DISEASE SPIROCHETES (BORRELIA BURGDORFERI) BY TICK VECTORS (IXODES SCAPULARIS)
US20010046499A1 (en) * 1999-12-03 2001-11-29 Kantor Fred S. Tick antigens and compositions and methods comprising them
EP1283716B1 (en) 2000-04-25 2012-03-28 Merial Limited Vaccine comprising a tick cement protein
AU2003223767A1 (en) 2002-04-29 2003-11-17 The Board Of Regents For Oklahoma State University Protective antigens for the control of ixodes species infestations

Also Published As

Publication number Publication date
MXPA04010793A (es) 2005-09-12
BRPI0309787A2 (pt) 2017-06-20
AU2003223767A8 (en) 2003-11-17
AU2003223767A1 (en) 2003-11-17
EP1534328A4 (en) 2007-01-10
US7214784B2 (en) 2007-05-08
WO2003093416A3 (en) 2005-04-07
US20040022795A1 (en) 2004-02-05
EP1534328A2 (en) 2005-06-01
WO2003093416A2 (en) 2003-11-13

Similar Documents

Publication Publication Date Title
CY1110868T1 (el) Ελαχιστη αλληλουχια dna που δρα ως μονωτης της χρωματινης και η χρηση της στην πρωτεϊνικη εκφραση
ATE318899T1 (de) Fusionsproteine, die stressproteine beinhalten, zum hervorrufen einer immunantwort
Deepe Jr et al. A protective domain of heat-shock protein 60 from Histoplasma capsulatum
WO2004083404A3 (en) Gene therapy vectors having reduced immunogenicity based on cd8 alpha-chain
WO2004076489A8 (en) Modified antibody
AU2003244855A1 (en) Method to enhance an immune response of nucleic acid vaccination
ATE312920T1 (de) Dna immunisierung gegen chlamydia infektion
NO20004972L (no) Derivater av pneumokokkale kolinbindende proteiner for vaksiner
WO2023094713A3 (en) Coronavirus vaccine
MX2009007572A (es) Proteinas de fusion que contienen los antigenos de rechazo de tumor ny-eso-1 y.
DK1530637T3 (da) Carlsberg-subtilisin-proteiner med nedsat immunogenitet
ATE473236T1 (de) Antigene von piscirickettsia salmonis und deren verwendung
BR0110394A (pt) Proteìna anti-congelamento, sequência nucleica, vetor, método para produzir uma proteìna anti-congelamento, organismo geneticamente modificado, extrato contendo proteìna, e, produto alimentìcio
DK1272633T3 (da) Præparater og fremgangsmåder til dendritisk celle-baseret immunterapi
EA200600738A1 (ru) Способ
ATE231550T1 (de) Gezielte t-lymfozyten
WO2021247715A3 (en) Immunogenic francisella antigens and their use in immunization of fish against francisellosis
ATE494377T1 (de) Vakzine gegen ipnv die aus hefezellen isoliert werden
WO2003093416A3 (en) Protective antigens for the control of ixodes species infestations
DE60239753D1 (de) Impfstoff gegen infektiöses lachsanämievirus
DE69633919D1 (de) Mehrzweckvakzine gegen umhüllte viren
EP0652769A1 (en) Vaccines against Metazoon parasites.
ATE378351T1 (de) Therapeutische impfzusammensetzung zur verhütung und behandlung von erkrankungen bei säugetieren
DE60143940D1 (de) Synthetischer impfstoff zur zeckeneindämmung
BRPI0604365A (pt) polipeptìdeo isolado, composição de vacina anti-carrapato de múltiplas espécies, e, uso dos mesmos

Legal Events

Date Code Title Description
B06H Technical and formal requirements: requirement cancelled [chapter 6.8 patent gazette]

Free format text: ANULADA PUBLICACAO 6.7 DA RPI 1878 DE 02/01/2007 POIS A MESMA FOI INDEVIDA.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]
B11Q Dismissal: the certificate of addition was not accessory to any patent, or a patent which was nominated accessory and no longer exists

Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: